0000902664-12-000455.txt : 20120214 0000902664-12-000455.hdr.sgml : 20120214 20120214162509 ACCESSION NUMBER: 0000902664-12-000455 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111231 FILED AS OF DATE: 20120214 DATE AS OF CHANGE: 20120214 EFFECTIVENESS DATE: 20120214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Noble Partners, L. P. CENTRAL INDEX KEY: 0001350882 IRS NUMBER: 043116388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-11605 FILM NUMBER: 12610291 BUSINESS ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-646-6500 MAIL ADDRESS: STREET 1: 265 FRANKLIN STREET STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02110 13F-HR 1 p12-0399form13fhr.txt NOBLE PARTNERS, L. P. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2011 ---------------------------- Check here if Amendment [ ]; Amendment Number: ----- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: NOBLE PARTNERS, L.P. -------------------------------------------------- Address: 265 FRANKLIN ST., 21ST FLOOR -------------------------------------------------- BOSTON, MA 02110 -------------------------------------------------- Form 13F File Number: 28-11605 ------------------ The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: GEORGE L. NOBLE -------------------------------------------------- Title: PRESIDENT, PEAK ASSET MGT., INC., GENERAL PARTNER, NOBLE PARTNERS, L.P. -------------------------------------------------- Phone: 617-646-6500 -------------------------------------------------- Signature, Place, and Date of Signing: /s/ GEORGE L. NOBLE BOSTON, MA 2/14/2012 ------------------------ ------------------------------ ---------- [Signature] [City, State] [Date] Report Type (Check only one.): [ x ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ------------- Form 13F Information Table Entry Total: 21 ------------- Form 13F Information Table Value Total: $ 14,177 ------------- (in thousands) Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE
FORM 13F INFORMATION TABLE COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 ---------------------------- -------------- --------- -------- ----------------- ---------- -------- ------------------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ---------------------------- -------------- --------- -------- -------- --- ---- ---------- -------- ------- ------ ---- ACADIA PHARMACEUTICALS INC COM 004225108 22 20,000 SH SOLE 20,000 0 0 AKORN INC COM 009728106 556 50,000 SH SOLE 50,000 0 0 ALLERGAN INC COM 018490102 877 10,000 SH SOLE 10,000 0 0 AMARIN CORP PLC SPONS ADR NEW 023111206 449 60,000 SH SOLE 60,000 0 0 ARIAD PHARMACEUTICALS INC COM 04033A100 1,041 85,000 SH SOLE 85,000 0 0 CARDIOME PHARMA CORP COM NEW 14159U202 69 26,100 SH SOLE 26,100 0 0 CELGENE CORP COM 151020104 676 10,000 SH SOLE 10,000 0 0 COMMUNITY HEALTH SYS INC NEW COM 203668108 175 10,000 SH SOLE 10,000 0 0 ELAN PLC ADR 284131208 687 50,000 SH SOLE 50,000 0 0 GOLAR LNG LTD BERMUDA SHS G9456A100 1,533 50,000 SH SOLE 50,000 0 0 GREEN PLAINS RENEWABLE ENERG COM 393222104 195 20,000 SH SOLE 20,000 0 0 INHIBITEX INC COM 45719T103 328 30,000 SH SOLE 30,000 0 0 INSULET CORP COM 45784P101 377 20,000 SH SOLE 20,000 0 0 JAZZ PHARMACEUTICALS INC COM 472147107 966 25,000 SH SOLE 25,000 0 0 JOHNSON & JOHNSON COM 478160104 525 8,000 SH SOLE 8,000 0 0 NPS PHARMACEUTICALS INC COM 62936P103 560 85,000 SH SOLE 85,000 0 0 OPTIMER PHARMACEUTICALS INC COM 68401H104 490 40,000 SH SOLE 40,000 0 0 PACIFIC ETHANOL INC COM NEW 69423U206 954 900,000 SH SOLE 900,000 0 0 PERRIGO CO COM 714290103 292 3,000 SH SOLE 3,000 0 0 UNITED STATES NATL GAS FUND UNIT NEW 912318110 2,907 450,000 SH PUT SOLE 450,000 0 0 VERTEX PHARMACEUTICALS INC COM 92532F100 498 15,000 SH SOLE 15,000 0 0